208 related articles for article (PubMed ID: 367678)
1. Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension.
Teeuw AH; Leenen FH; Geyskes GG; Boer P
Clin Pharmacol Ther; 1979 Mar; 25(3):294-302. PubMed ID: 367678
[TBL] [Abstract][Full Text] [Related]
2. Effects of atenolol and propranolol when added to long-term antihypertensive diuretic therapy.
van Rooijen GJ; Boer P; Dorhout Mees EJ; Geyskes GG
Clin Pharmacol Ther; 1979 Oct; 26(4):420-7. PubMed ID: 487688
[TBL] [Abstract][Full Text] [Related]
3. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
[TBL] [Abstract][Full Text] [Related]
4. Atenolol and chlorthalidone in combination for hypertension.
Bateman DN; Dean CR; Mucklow JC; Bulpitt CJ; Dollery CT
Br J Clin Pharmacol; 1979 Apr; 7(4):357-63. PubMed ID: 375958
[TBL] [Abstract][Full Text] [Related]
5. A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.
Ishizaki T; Oyama Y; Suganuma T; Sasaki T; Nakaya H; Shibuya T; Sato T
Br J Clin Pharmacol; 1983 Jul; 16(1):17-25. PubMed ID: 6349668
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive effect of atenolol alone or combined with chlorthalidone in patients with essential hypertension.
Velasco M; Guevara J; Morillo J; Ramírez A; Urbina-Quintana A; Hernández-Pieretti O
Br J Clin Pharmacol; 1980 May; 9(5):499-504. PubMed ID: 6994790
[No Abstract] [Full Text] [Related]
7. The effects of a beta 1-blocking agent, atenolol, on blood pressure, plasma renin activity and prostaglandin F2 alpha excretion in patients with essential hypertension.
Pitkäjärvi T; Ylitalo P; Metsä-Ketelä T; Vapaatalo H
Acta Med Scand; 1979; 206(1-2):107-13. PubMed ID: 484251
[TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with tibalosine in essential hypertension.
Staessen J; Fagard R; Fiocchi R; Lijnen P; M'Buyamba-Kabangu JR; Amery A
Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):162-76. PubMed ID: 3516092
[TBL] [Abstract][Full Text] [Related]
9. Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians.
Salako LA; Falase AO; Aderounmu AF; Walker O
Afr J Med Med Sci; 1990 Mar; 19(1):57-61. PubMed ID: 2109522
[TBL] [Abstract][Full Text] [Related]
10. The effects of combined angiotensin converting enzyme inhibition and beta-adrenoceptor blockade on plasma renin activity in anaesthetized dogs.
Cambridge D; Whiting MV; Butterfield LJ; Allan G
Br J Pharmacol; 1992 Jun; 106(2):342-7. PubMed ID: 1356560
[TBL] [Abstract][Full Text] [Related]
11. Dose response for blood pressure and degree of cardiac beta-blockade with atenolol.
Marshall AJ; Barritt DW; Heaton S; Harry JD
Postgrad Med J; 1979 Sep; 55(646):537-40. PubMed ID: 390528
[TBL] [Abstract][Full Text] [Related]
12. Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension.
Epstein SE; LUbbe WF
S Afr Med J; 1977 Nov; 52(22):875-9. PubMed ID: 343273
[TBL] [Abstract][Full Text] [Related]
13. Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated Hypertension.
Mehanna M; Wang Z; Gong Y; McDonough CW; Beitelshees AL; Gums JG; Chapman AB; Schwartz GL; Bailey KR; Johnson JA; Turner ST; Cooper-DeHoff RM
Am J Hypertens; 2019 Jun; 32(7):668-675. PubMed ID: 30753254
[TBL] [Abstract][Full Text] [Related]
14. Controlled clinical trial of cadralazine as a second-step drug in the treatment of hypertension.
Catalano M; Parini J; Romano M; Libretti A
Eur J Clin Pharmacol; 1985; 28(2):135-8. PubMed ID: 3886402
[TBL] [Abstract][Full Text] [Related]
15. Pindolol: effects on blood pressure and plasma renin activity.
Glassock RJ; Weitzman RE; Bennett CM; Maxwell M; Hamilton B; Winer N; Kirkendall W; Gonasun L
Am Heart J; 1982 Aug; 104(2 Pt 2):421-5. PubMed ID: 7048878
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effectiveness of a beta blocker (atenolol) and a diuretic (chlorthalidone) in black hypertensive patients.
Grell GA; Forrester TE; Alleyne GA
South Med J; 1984 Dec; 77(12):1524-9. PubMed ID: 6390696
[TBL] [Abstract][Full Text] [Related]
17. Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hypertension.
González-Gómez A; García-Barreto D; Gamio Capestany F; Hernández-Cañero A; Fong Chi S
Cor Vasa; 1982; 24(6):422-8. PubMed ID: 6764167
[TBL] [Abstract][Full Text] [Related]
18. Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity.
Nilsson OR; Karlberg BE; Ohlsson O; Thulin T; Tolagen K
Acta Med Scand; 1979; 206(4):303-8. PubMed ID: 506802
[TBL] [Abstract][Full Text] [Related]
19. Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension.
Geyskes GG; Boer P; Vos J; Leenen FH; Mees EJ
Circ Res; 1975 Jun; 36(6 Suppl 1):248-56. PubMed ID: 1093756
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of the haemodynamic interaction between atenolol, a cardioselective beta-adrenoreceptor-blocking agent, and chlorthalidone in hypertensive patients.
Velasco M; Guevara J; Morillo J; Ramírez A; Urbina-Quintana A; Hernandez-Pieretti O
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():363s-365s. PubMed ID: 396082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
